IFNG and neoplasm: The systemic antitumor immune responses for local and abscopal tumor control, significantly increased by increasing the tumor-infiltrating effector memory CD8+ T cells and systemic IFNγ secretion along with the accumulation of migratory CXCL10-secreting CD103+ DCs, contributing to tumor antigen cross-presentation in the TME (31).